1. Home
  2. RIO vs SNY Comparison

RIO vs SNY Comparison

Compare RIO & SNY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Rio Tinto Plc

RIO

Rio Tinto Plc

HOLD

Current Price

$96.37

Market Cap

140.3B

ML Signal

HOLD

Logo Sanofi ADS

SNY

Sanofi ADS

HOLD

Current Price

$48.32

Market Cap

119.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RIO
SNY
Founded
1873
1994
Country
United Kingdom
France
Employees
N/A
N/A
Industry
Metal Mining
Biotechnology: Pharmaceutical Preparations
Sector
Basic Materials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
140.3B
119.4B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
RIO
SNY
Price
$96.37
$48.32
Analyst Decision
Buy
Buy
Analyst Count
2
6
Target Price
$85.00
$61.50
AVG Volume (30 Days)
4.9M
3.8M
Earning Date
02-19-2026
01-29-2026
Dividend Yield
3.85%
3.37%
EPS Growth
N/A
44.16
EPS
6.28
7.52
Revenue
$53,729,000,000.00
$54,850,299,422.00
Revenue This Year
$7.31
$2.70
Revenue Next Year
$3.52
$6.84
P/E Ratio
$15.35
$12.62
Revenue Growth
N/A
5.49
52 Week Low
$51.67
$44.62
52 Week High
$97.11
$60.12

Technical Indicators

Market Signals
Indicator
RIO
SNY
Relative Strength Index (RSI) 72.05 53.95
Support Level $89.63 $47.20
Resistance Level $97.11 $47.89
Average True Range (ATR) 2.01 0.73
MACD 0.42 0.17
Stochastic Oscillator 85.86 83.58

Price Performance

Historical Comparison
RIO
SNY

About RIO Rio Tinto Plc

Rio Tinto is a global diversified miner. Iron ore is the dominant commodity, with significantly lesser contributions from copper, aluminum, diamonds, gold, and industrial minerals. The 1995 merger of RTZ and CRA, via a dual-listed structure, created the present-day company. The two operate as a single business entity, with shareholders in each company having equivalent economic and voting rights. Major assets included the Pilbara iron ore operations, a 30% stake in the Escondida copper mine, 66%-ownership of the Oyu Tolgoi copper mine in Mongolia, the Weipa and Gove bauxite mines in Australia, and six hydro-powered aluminum smelters in Canada.

About SNY Sanofi ADS

Sanofi develops and markets drugs with a concentration in immunology, vaccines, and rare diseases. Although the company offers a diverse array of drugs, its highest revenue generator, Dupixent, accounts for approximately 30% of total sales. Profits for this immunology blockbuster drug are shared with Regeneron. About 45% of total revenue comes from the United States, 20% from Europe, and 6% from China.

Share on Social Networks: